These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 28618997

  • 1. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
    Shoshan-Barmatz V, Krelin Y, Chen Q.
    Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
    [Abstract] [Full Text] [Related]

  • 2. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D, Shoshan-Barmatz V.
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [Abstract] [Full Text] [Related]

  • 3. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS.
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [Abstract] [Full Text] [Related]

  • 4. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S, Keinan N, Ben-Hail D, Arif T, Shoshan-Barmatz V.
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [Abstract] [Full Text] [Related]

  • 5. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N, Pahima H, Ben-Hail D, Shoshan-Barmatz V.
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [Abstract] [Full Text] [Related]

  • 6. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V, Mizrachi D, Keinan N.
    Prog Mol Biol Transl Sci; 2013 Jul; 117():303-34. PubMed ID: 23663973
    [Abstract] [Full Text] [Related]

  • 7. VDAC1 functions in Ca2+ homeostasis and cell life and death in health and disease.
    Shoshan-Barmatz V, Krelin Y, Shteinfer-Kuzmine A.
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [Abstract] [Full Text] [Related]

  • 8. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D, Begas-Shvartz R, Shalev M, Shteinfer-Kuzmine A, Gruzman A, Reina S, De Pinto V, Shoshan-Barmatz V.
    J Biol Chem; 2016 Nov 25; 291(48):24986-25003. PubMed ID: 27738100
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V, Keinan N, Abu-Hamad S, Tyomkin D, Aram L.
    Biochim Biophys Acta; 2010 Nov 25; 1797(6-7):1281-91. PubMed ID: 20214874
    [Abstract] [Full Text] [Related]

  • 10. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A, Dangoor L, Nakdimon I, Ben-Hail D, Mizrachi D, Shoshan-Barmatz V.
    J Biol Chem; 2015 Dec 25; 290(52):30670-83. PubMed ID: 26542804
    [Abstract] [Full Text] [Related]

  • 11. Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis.
    Mader A, Abu-Hamad S, Arbel N, Gutiérrez-Aguilar M, Shoshan-Barmatz V.
    Biochem J; 2010 Jul 01; 429(1):147-55. PubMed ID: 20420578
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial VDAC, the Na+/Ca2+ Exchanger, and the Ca2+ Uniporter in Ca2+ Dynamics and Signaling.
    Shoshan-Barmatz V, De S.
    Adv Exp Med Biol; 2017 Jul 01; 981():323-347. PubMed ID: 29594867
    [Abstract] [Full Text] [Related]

  • 13. The Mitochondrial Voltage-Dependent Anion Channel 1, Ca2+ Transport, Apoptosis, and Their Regulation.
    Shoshan-Barmatz V, De S, Meir A.
    Front Oncol; 2017 Jul 01; 7():60. PubMed ID: 28443244
    [Abstract] [Full Text] [Related]

  • 14. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases.
    Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A.
    Biomolecules; 2020 Oct 26; 10(11):. PubMed ID: 33114780
    [Abstract] [Full Text] [Related]

  • 15. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V, Krelin Y, Shteinfer-Kuzmine A, Arif T.
    Front Oncol; 2017 Oct 26; 7():154. PubMed ID: 28824871
    [Abstract] [Full Text] [Related]

  • 16. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T, Shteinfer A, Admoni L, Raviv Z, Sela I, Levi I, Shoshan-Barmatz V.
    Cell Death Dis; 2013 Sep 19; 4(9):e809. PubMed ID: 24052077
    [Abstract] [Full Text] [Related]

  • 17. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/β-catenin signaling pathway.
    Yang X, Tang S, Dai C, Li D, Zhang S, Deng S, Zhou Y, Xiao X.
    Food Chem Toxicol; 2017 Jul 19; 105():161-176. PubMed ID: 28343033
    [Abstract] [Full Text] [Related]

  • 18. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
    Abu-Hamad S, Arbel N, Calo D, Arzoine L, Israelson A, Keinan N, Ben-Romano R, Friedman O, Shoshan-Barmatz V.
    J Cell Sci; 2009 Jun 01; 122(Pt 11):1906-16. PubMed ID: 19461077
    [Abstract] [Full Text] [Related]

  • 19. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V, Nahon-Crystal E, Shteinfer-Kuzmine A, Gupta R.
    Pharmacol Res; 2018 May 01; 131():87-101. PubMed ID: 29551631
    [Abstract] [Full Text] [Related]

  • 20. VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
    Aram L, Geula S, Arbel N, Shoshan-Barmatz V.
    Biochem J; 2010 Apr 14; 427(3):445-54. PubMed ID: 20192921
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.